Cargando…

Metabolic Biomarkers Affecting Cell Proliferation and Prognosis in Polycythemia Vera

SIMPLE SUMMARY: Polycythemia vera (PV) is a malignant neoplastic disease. Abnormal cell metabolism is a new feature of malignant proliferation of tumor cells. Our study described the global metabolic profile of PV patients, analyzed their relationship with cell proliferation, screened prognosis-rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ziqing, Lv, Yan, Yang, Erpeng, Li, Yujin, Wang, Dehao, Hu, Guang, Li, Yumeng, Wang, Mingjing, Liu, Weiyi, Sun, Mingqian, Hu, Xiaomei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563618/ https://www.ncbi.nlm.nih.gov/pubmed/36230834 http://dx.doi.org/10.3390/cancers14194913

Ejemplares similares

TET2 Mutation May Be More Valuable in Predicting Thrombosis in ET Patients Compared to PV Patients: A Preliminary Report
por: Wang, Ziqing, et al.
Publicado: (2022)

Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis
por: Wang, Ziqing, et al.
Publicado: (2021)

Coagulation status and determinants of possible aspirin resistance in patients with essential thrombocythemia
por: Yang, Erpeng, et al.
Publicado: (2022)

Proteomic-Based Platelet Activation-Associated Protein SELP May Be a Novel Biomarker for Coagulation and Prognostic in Essential Thrombocythemia
por: Wang, Dehao, et al.
Publicado: (2023)

Comparison of the effects between MPL and JAK2V617F on thrombosis and peripheral blood cell counts in patients with essential thrombocythemia: a meta-analysis
por: Yang, Erpeng, et al.
Publicado: (2021)

Ruxolitinib in Myelofibrosis and Polycythemia Vera
por: Wolfe, Leah
Publicado: (2016)

Thromboembolic events in polycythemia vera
por: Griesshammer, Martin, et al.
Publicado: (2019)

Genetic Background of Polycythemia Vera
por: Regimbeau, Mathilde, et al.
Publicado: (2022)

Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera
por: Tang, Guilin, et al.
Publicado: (2017)

Differential cytokine network profile in polycythemia vera and secondary polycythemia
por: Cacemiro, Maira da Costa, et al.
Publicado: (2020)

Serum ferritin as a biomarker of polycythemia vera?
por: Langabeer, Stephen E.
Publicado: (2018)

Lemierre’s Syndrome in an Elderly Female Patient with Polycythemia Vera: Does Polycythemia Vera Predispose to Lemierre’s Syndrome?
por: Kundal, Sanchit V., et al.
Publicado: (2021)

PB2190: COMORBIDITIES PREDICT WORSE PROGNOSIS IN PATIENTS WITH POLYCYTHEMIA VERA
por: Arsenović, Isidora, et al.
Publicado: (2023)

Splenectomy Normalizes Hematocrit in Murine Polycythemia Vera
por: Mo, Jan-Rung, et al.
Publicado: (2009)

Polycythemia vera presenting with bilateral papilledema
por: Nithyanandam, Suneetha
Publicado: (2009)

Electrocardiographic Findings in Patients with Polycythemia Vera
por: Kayrak, Mehmet, et al.
Publicado: (2011)

Hypercalcemia in a Patient with Polycythemia Vera
por: Bae, Eun Hui, et al.
Publicado: (2012)

JAK2 Negative Polycythemia Vera
por: Geetha, J P, et al.
Publicado: (2010)

Chorea disclosing a polycythemia vera
por: Liu, Guidong, et al.
Publicado: (2014)

An oncolytic parasite to treat polycythemia vera
por: Rizvi, Syeda Taliya, et al.
Publicado: (2015)

Bilateral adrenal hemorrhage in polycythemia vera
por: Bhandari, Shruti, et al.
Publicado: (2016)

Therapy of polycythemia vera: is it time to change?
por: Passamonti, Francesco, et al.
Publicado: (2017)

Polycythemia vera treatment algorithm 2018
por: Tefferi, Ayalew, et al.
Publicado: (2018)

When hemolysis masks polycythemia vera
por: Derrieux, Coralie, et al.
Publicado: (2019)

Takotsubo Cardiomyopathy Associated with Polycythemia Vera
por: Basnet, Sijan, et al.
Publicado: (2018)

Is there a gender effect in polycythemia vera?
por: Palandri, Francesca, et al.
Publicado: (2020)

Polycythemia Vera Presenting as Hemorrhagic Stroke
por: Balagopal, Krishnan, et al.
Publicado: (2021)

Volumetric Splenomegaly in Patients With Polycythemia Vera
por: Lee, Myung-Won, et al.
Publicado: (2022)

Polycythemia Vera: Thinking Beyond the Hematocrit
por: Waggoner, Matthew
Publicado: (2023)

Exploration and identification of anoikis-related genes in polycythemia vera
por: Aini, Wufuer, et al.
Publicado: (2023)

Rapidly progressed aortic stenosis in a patient with previous diagnosis of polycythemia vera and post‐polycythemia vera myelofibrosis
por: Kiso, Shohei, et al.
Publicado: (2016)

Association of polycythemia vera with non‑cirrhotic portal hypertension in five patients: A case series
por: Zhang, Lili, et al.
Publicado: (2023)

The efficiency and safety of Shengxuening tablet on treating and preventing iron deficiency anemia: A systematic review and meta-analysis
por: Zhang, Yanyu, et al.
Publicado: (2022)

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
por: Tefferi, A, et al.
Publicado: (2013)

Cytoreductive treatment patterns among US veterans with polycythemia vera
por: Parasuraman, Shreekant, et al.
Publicado: (2018)

Idiopathic thrombocytopenic purpura coexisting with polycythemia vera
por: Niscola, Pasquale, et al.
Publicado: (2011)

Current and future treatment options for polycythemia vera
por: Griesshammer, Martin, et al.
Publicado: (2015)

Updates in the management of polycythemia vera and essential thrombocythemia
por: Bose, Prithviraj, et al.
Publicado: (2019)

Dermatomyositis Associated with Myelofibrosis following Polycythemia Vera
por: Fei, Naomi, et al.
Publicado: (2017)

Macroscopic Hematuria as the Initial Presentation of Polycythemia Vera
por: Oliveira, Sebastião Carlos de Sousa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u7a29a0h8mh69v2eqg6s0rk803